Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma.

Katia MancusoPaola TacchettiLucia PantaniSerena RocchiIlaria RizzelloIsola CaratozzoloGabriella De CiccoAlessio FuscoNicoletta TestoniCarolina TerragnaGiulia MarzocchiMarina MartelloEnrica BorsiLuca DozzaMichele CavoElena Zamagni

Published in: Bone marrow transplantation (2020)

Keyphrases

multiple myeloma
low dose
high dose
stem cells
newly diagnosed